ArticleTranslational lung cancer research2025
Deep learning-based classification of pleural malignancy using medical thoracoscopic images.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lightweight hybrid foundation model for lung cancer prognosis based on low-dose chest X-ray images.Translational lung cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant pleural effusion (MPE) is a frequent complication of advanced lung cancer, and rapid and accurate diagnosis is critical for timely therapeutic decision-making. Although medical thoracoscopy (MT) provides direct visualization and targeted biopsy, resulting in high diagnostic yield, the clinical utility of its findings is contingent on operator experience and subsequent confirmation via pathological analysis. Recent advances in deep learning have enabled automated image classification in various fields, but its application in thoracoscopic images remains unexplored. The aim of our study was to develop a deep learning-based model to classify pleural malignancy and to evaluate its diagnostic performance. Methods: We developed a deep learning-based classification model using thoracoscopic images obtained from 426 patients who underwent MT at Incheon St. Mary's Hospital between May 2015 and July 2024. After preprocessing and standardization of 4,932 images (2,093 benign, 2,839 malignant), we trained an InceptionV3-based convolutional neural network using transfer learning and online augmentation during training. Model performance was evaluated according to accuracy, precision, recall, the F1 score, the area under the receiver operating characteristic curve (ROC-AUC), and gradient-weighted class activation mapping (Grad-CAM) visualization. Results: In total, 4,932 thoracoscopic images from 426 patients were used to train and evaluate the model. In the test set, the InceptionV3-based model achieved a classification accuracy of 81.7% [95% confidence interval (CI): ± 3.5%], with a precision of 82.4% (95% CI: ±4.3%), recall of 86.6% (95% CI: ±3.8%), and F1 score of 84.6% (95% CI: ±3.0%). The AUC was 0.90 (95% CI: ±2.6%), indicating excellent discriminative performance. A confusion matrix indicated 165 true positives, 25 false negatives, 29 false positives, and 262 true negatives. Grad-CAM visualizations confirmed that the model consistently focused on visually relevant pleural abnormalities such as nodularity, thickening, and neovascularization. Notably, the model maintained high accuracy even in cases without overt tumor nodules. Conclusions: This study presents the first deep learning-based classification model of pleural malignancy using MT images. The model showed excellent diagnostic performance and has the potential to aid real-time clinical decision-making during thoracoscopy by suggesting malignant targets for biopsy or pleurodesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.